Severity of infections · people at risk of viral and bacterial infections
1 finding from 1 review
Harms · people at risk of viral and bacterial infections
1 finding from 1 review
Loneliness · older people
1 finding from 1 review
Social Isolation · older people
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Symptoms of depression · older people
1 finding from 1 review
Quality of life · older people
1 finding from 1 review
Intervention not reported
Mortality at longest · adult (≥ 18 years of age) patients receiving mechanical ventilation (via either an endotracheal tube or a tracheostomy) for acute…
It is very uncertain whether the intervention changes mortality at longest (very low certainty).
1 finding from 1 review
Intervention not reported
Number of days ventilated · adult (≥ 18 years of age) patients receiving mechanical ventilation (via either an endotracheal tube or a tracheostomy) for acute…
1 finding from 1 review
Intervention not reported
Requirement for inotropic support (scale from 0 to 28, days of catecholamine use) · adult (≥ 18 years of age) patients receiving mechanical ventilation (via either an endotracheal tube or a tracheostomy) for acute…
1 finding from 1 review
Intervention not reported
Requirement for renal replacement therapy ( · adult (≥ 18 years of age) patients receiving mechanical ventilation (via either an endotracheal tube or a tracheostomy) for acute…
It is very uncertain whether the intervention changes requirement for renal replacement therapy ( (very low certainty).
1 finding from 1 review
Intervention not reported
Quality of life · adult (≥ 18 years of age) patients receiving mechanical ventilation (via either an endotracheal tube or a tracheostomy) for acute…
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
OS · adults with Hodgkin's lymphoma
1 finding from 1 review
QoL · adults with Hodgkin's lymphoma
1 finding from 1 review
PFS · adults with Hodgkin's lymphoma
1 finding from 1 review
Response rate · adults with Hodgkin's lymphoma
1 finding from 1 review
Treatment‐related mortality · adults with Hodgkin's lymphoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Grades 3 and 4 adverse events · adults with Hodgkin's lymphoma
1 finding from 1 review
SAEs · adults with Hodgkin's lymphoma
1 finding from 1 review
Time to death from any cause (here: overall mortality at 12‐month
Pembrolizumab probably leads to lower time to death from any cause (here: overall mortality at 12‐month compared with chemotherapy (moderate certainty).
1 finding from 1 review
Quality of life (Change from baseline to week 15)
Pembrolizumab may leads to higher quality of life (Change from baseline to week 15) compared with chemotherapy (low certainty).
1 finding from 1 review